Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Abstract A94: CXCR2 macromolecular complex in pancreatic cancer: A potential therapeutic target in tumor growth.

Shuo Wang, Yanning Wu, Yuning Hou, Marcello P. Castelvetere, Xiaoqing Guan, Jacob J. Oblak, Sanjeev Banerjee, Theresa M. Filtz, Fazul H. Sarkar, Chunying Li

Cancer Res (2012) 72 (14_Supplement): A94.

https://doi.org/10.1158/1538-7445.PANCA2012-A94

Published: 03 April 2014

View article titled, Abstract A94: CXCR2 macromolecular complex in pancreatic cancer: A potential therapeutic target in tumor growth.

Journal Articles

Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer.

Kaladhar B. Reddy, Shuping Yin, R. Bonfil Daniel, Sanjeev Banerjee, Fazlul Sarkar, Seema Sethi

Cancer Res (2013) 73 (8_Supplement): 241.

https://doi.org/10.1158/1538-7445.AM2013-241

Published: 15 April 2013

View article titled, Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer.

Journal Articles

Abstract 3296: The loss of miR-34a and activation of Notch-1 leads to aggressiveness of pancreatic cancer cells, which could be attenuated by CDF.

Bin Bao, Shadan S. Ali, Asfar Azmi, Aamir Ahmad, Dejuan Kong, Yiwei Li, Sanjeev Banerjee, Amro Aboukameel, Subhash Padhye, Fazlul Sarkar

Cancer Res (2013) 73 (8_Supplement): 3296.

https://doi.org/10.1158/1538-7445.AM2013-3296

Published: 15 April 2013

View article titled, Abstract 3296: The loss of miR-34a and activation of Notch-1 leads to aggressiveness of pancreatic cancer cells, which could be attenuated by CDF.

Journal Articles

Abstract 2578: Anticancer action of garcinol in vitro and in vivo is mediated through inhibition of STAT-3 signaling

Aamir Ahmad, Amro Aboukameel, Shadan Ali, Yiwei Li, Bin Bao, Dejuan Kong, Sanjeev Banerjee, Fazlul H. Sarkar

Cancer Res (2012) 72 (8_Supplement): 2578.

https://doi.org/10.1158/1538-7445.AM2012-2578

Published: 15 April 2012

View article titled, Abstract 2578: Anticancer action of garcinol in vitro and in vivo is mediated through inhibition of STAT-3 signaling

Journal Articles

Abstract 2698: Improved therapeutic activity of Isoflavone-G2535 and Docetaxel combination in hormone refractory prostate cancer

Sanjeev Banerjee, Shadan Ali, Asfar Azmi, Dejuan Kong, Aamir Ahmad, Bin Bao, Fazlul H. Sarkar

Cancer Res (2012) 72 (8_Supplement): 2698.

https://doi.org/10.1158/1538-7445.AM2012-2698

Published: 15 April 2012

View article titled, Abstract 2698: Improved therapeutic activity of Isoflavone-G2535 and Docetaxel combination in hormone refractory prostate cancer

Journal Articles

Abstract 3328: Targeted inactivation of EZH2 by CDF inhibits pancreatic tumor growth mediated by re-expression of lost miRNAs in tumors

Bin Bao, Shadan Ali, Sanjeev Banerjee, Farah Logna, Asfar Azmi, Dejuan Kong, Aamir Ahmad, Yiwei Li, Subhash Padhye, Hazlul H. Sarkar

Cancer Res (2012) 72 (8_Supplement): 3328.

https://doi.org/10.1158/1538-7445.AM2012-3328

Published: 15 April 2012

View article titled, Abstract 3328: Targeted inactivation of EZH2 by CDF inhibits pancreatic tumor growth mediated by re-expression of lost miRNAs in tumors

Journal Articles

Abstract 5196: CDF inhibits cell migration by inactivating cancer stem cell markers, and expression of VEGF, IL-6 and miR-21 in human pancreatic and prostate cancer cells under hypoxic condition

Bin Bao, Shadan Ali, Aamir Ahmad, Asfar S. Azmi, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, Subhash Padhye, Fazlul H. Sarkar

Cancer Res (2012) 72 (8_Supplement): 5196.

https://doi.org/10.1158/1538-7445.AM2012-5196

Published: 15 April 2012

View article titled, Abstract 5196: CDF inhibits cell migration by inactivating cancer stem cell markers, and expression of VEGF, IL-6 and miR-21 in human pancreatic and prostate cancer cells under hypoxic condition

Journal Articles

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Bin Bao, Shadan Ali, Sanjeev Banerjee, Zhiwei Wang, Farah Logna, Asfar S. Azmi, Dejuan Kong, Aamir Ahmad, Yiwei Li, Subhash Padhye, Fazlul H. Sarkar

Cancer Res (2012) 72 (1): 335–345.

https://doi.org/10.1158/0008-5472.CAN-11-2182

Published: 02 January 2012

View article titled, Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Journal Articles

Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Bin Bao, Shadan Ali, Dejuan Kong, Sanila H. Sarkar, Zhiwei Wang, Sanjeev Banerjee, Amro Aboukameel, Subhash Padhye, Philip A. Philp, Fazlul H. Sarkar

Cancer Res (2011) 71 (8_Supplement): 173.

https://doi.org/10.1158/1538-7445.AM2011-173

Published: 15 April 2011

View article titled, Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Journal Articles

Abstract 3524: Structure-based molecular docking of DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer

Aruna S. Jaiswal, Sanjeev Banerjee, Ritu Aneja, Fazlul H. Sarkar, David A. Ostrov, Satya Narayan

Cancer Res (2011) 71 (8_Supplement): 3524.

https://doi.org/10.1158/1538-7445.AM2011-3524

Published: 15 April 2011

View article titled, Abstract 3524: Structure-based molecular docking of DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer

Journal Articles

Abstract 3706: Novel analogs of dietary thymoquinone with superior bioavailability and anti-tumor activity against GI cancers

Asfar S. Azmi, Subhash Padhye, Sanjeev Banerjee, Amro Aboukameel, Fazlul H. Sarkar, Ramzi M. Mohammad

Cancer Res (2011) 71 (8_Supplement): 3706.

https://doi.org/10.1158/1538-7445.AM2011-3706

Published: 15 April 2011

View article titled, Abstract 3706: Novel analogs of dietary thymoquinone with superior bioavailability and anti-tumor activity against GI cancers

Journal Articles

Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Zhiwei Wang, Sanjeev Banerjee, Aamir Ahmad, Asfar S. Azmi, Bin Bao, Shadan Ali, Ramzi M. Mohammad, Lucio Miele, Murray Korc, Fazlul H. Sarkar

Cancer Res (2011) 71 (8_Supplement): 2385.

https://doi.org/10.1158/1538-7445.AM2011-2385

Published: 15 April 2011

View article titled, Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Journal Articles

Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Shadan Ali, Aamir Ahmad, Sanjeev Banerjee, Subhash Padhye, Kristin Dominiak, Jacqueline M. Schaffert, Zhiwei Wang, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2010) 70 (9): 3606–3617.

https://doi.org/10.1158/0008-5472.CAN-09-4598

Published: 28 April 2010

View article titled, Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Journal Articles

Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

Sanjeev Banerjee, Zhiwei Wang, Asfar Azmi, Dejuan Kong, Aamir Ahmad, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 2561.

https://doi.org/10.1158/1538-7445.AM10-2561

Published: 15 April 2010

View article titled, Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

Journal Articles

Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Aamir Ahmad, Dejuan Kong, Zhiwei Wang, Raza Ali, Sanjeev Banerjee, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 3118.

https://doi.org/10.1158/1538-7445.AM10-3118

Published: 15 April 2010

View article titled, Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Journal Articles

Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Asfar S. Azmi, Philip A. Philip, Amro Aboukameel, Sanjeev Banerjee, Zhiwei Wang, Shaomeng Wang, Dajun Yang, Fazlul H. Sarkar, Ramzi M. Mohammad

Cancer Res (2010) 70 (8_Supplement): 4535.

https://doi.org/10.1158/1538-7445.AM10-4535

Published: 15 April 2010

View article titled, Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Journal Articles

Abstract 5420: Multi-targeted approach for inhibiting pancreatic tumor growth in vivo consistent with in vitro results

Shadan Ali, Sanjeev Banerjee, Jacqueline M. Schaffert, Bassel F. El-Rayes, Philip A. Philip, Fazlul H. Sarkar

Cancer Res (2010) 70 (8_Supplement): 5420.

https://doi.org/10.1158/1538-7445.AM10-5420

Published: 15 April 2010

View article titled, Abstract 5420: Multi-targeted approach for inhibiting pancreatic tumor growth in vivo consistent with in vitro results

Journal Articles

Abstract 692: Antitumor activity of novel structure-based chemotherapeutic agent for the intervention of colorectal cancer

Aruna S. Jaiswal, Sanjeev Banerjee, Harekrushna Panda, Charles D. Bulkin, Tadahide Izumi, Fazlul H. Sarkar, David A. Ostrov, Satya Narayan

Cancer Res (2010) 70 (8_Supplement): 692.

https://doi.org/10.1158/1538-7445.AM10-692

Published: 15 April 2010

View article titled, Abstract 692: Antitumor activity of novel structure-based chemotherapeutic agent for the intervention of colorectal cancer

Journal Articles

3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Sanjeev Banerjee, Zhiwei Wang, Dejuan Kong, Fazlul H. Sarkar

Cancer Res (2009) 69 (13): 5592–5600.

https://doi.org/10.1158/0008-5472.CAN-09-0838

Published: 01 July 2009

View article titled, 3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

Sanjeev Banerjee, Ahmed O. Kaseb, Zhiwei Wang, Deujan Kong, Mussop Mohammad, Subhash Padhye, Fazlul H. Sarkar, Ramzi M. Mohammad

Cancer Res (2009) 69 (13): 5575–5583.

https://doi.org/10.1158/0008-5472.CAN-08-4235

Published: 01 July 2009

View article titled, Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

NARROW

Abstract A94: CXCR2 macromolecular complex in pancreatic cancer: A potential therapeutic target in tumor growth.

Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer.

Abstract 3296: The loss of miR-34a and activation of Notch-1 leads to aggressiveness of pancreatic cancer cells, which could be attenuated by CDF.

Abstract 2578: Anticancer action of garcinol in vitro and in vivo is mediated through inhibition of STAT-3 signaling

Abstract 2698: Improved therapeutic activity of Isoflavone-G2535 and Docetaxel combination in hormone refractory prostate cancer

Abstract 3328: Targeted inactivation of EZH2 by CDF inhibits pancreatic tumor growth mediated by re-expression of lost miRNAs in tumors

Abstract 5196: CDF inhibits cell migration by inactivating cancer stem cell markers, and expression of VEGF, IL-6 and miR-21 in human pancreatic and prostate cancer cells under hypoxic condition

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

Abstract 173: Targeted killing of cancer stem-like cells by a novel analogue of curcumin

Abstract 3524: Structure-based molecular docking of DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer

Abstract 3706: Novel analogs of dietary thymoquinone with superior bioavailability and anti-tumor activity against GI cancers

Abstract 2385: Activated Kras and INK4a/Arf deficiency cooperate to produce pancreatic cancer involved with Notch and NF-κB pathways

Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF

Abstract 2561: Genistein restored chemosensitivity to oxaliplatin in gemcitabine resistant pancreatic cancer cells in vitro and in orthotopic xenograft mouse model

Abstract 3118: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulation of Notch and NF-κB signaling pathways

Abstract 4535: MDM2 inhibitor MI-319 in combination with cisplatin/oxaliplatin is an effective treatment for pancreatic cancer independent of p53 function

Abstract 5420: Multi-targeted approach for inhibiting pancreatic tumor growth in vivo consistent with in vitro results

Abstract 692: Antitumor activity of novel structure-based chemotherapeutic agent for the intervention of colorectal cancer

3,3′-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only